Product
Azopt
Aliases
Azopt 1%
3 clinical trials
4 indications
Indication
GlaucomaIndication
Open Angle or Ocular HypertensionIndication
Open-AngleIndication
ocular hypertensionClinical trial
Multi-Center, Randomized, Double-Masked, Active Controlled, Parallel Group Study to Compare Perrigo's Brinzolamide Ophthalmic Suspension 1% to Azopt® in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Both EyesStatus: Completed, Estimated PCD: 2020-02-26
Clinical trial
A BIOEQUIVALENCE STUDY OF THE GENERIC BRINZOLAMIDE 1% OPHTHALMIC SUSPENSION COMPARED TO REFERENCE LISTED DRUG AZOPT® (BRINZOLAMIDE) OPHTHALMIC SUSPENSION 1% IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSIONStatus: Completed, Estimated PCD: 2018-11-17